VA testosterone replacement therapy, the current rules

The VA does not treat testosterone replacement therapy as a request followed by a single lab result. Its March 2025 criteria for use require documented signs and symptoms plus a biochemical assessment. The workup starts with a fasting total testosterone draw between 6 and 10 in the morning. If the result is below the local reference range, it must be confirmed with another fasting draw in the same morning window on a separate occasion, giving at least 2 confirmed low results before treatment decisions [1]. The current gate responds to a documented problem in older prescribing practice, not a desire to make care harder [1][2].

What does the VA require before TRT review?

The VA criteria for use, the document that sets the clinical conditions for a medication, require 2 kinds of evidence. First, your record needs documented signs and symptoms that could support low testosterone. Second, the laboratory work needs to show a low fasting total testosterone result confirmed on at least 2 separate occasions [1].

That means a veteran asking about TRT should expect the provider to discuss the symptoms and the reason for testing before ordering labs. The VA guidance says evaluation should be reserved for males with specific signs and symptoms, findings associated with hypogonadism such as infertility or unexplained anemia, or a history of conditions that can cause low testosterone [1].

The lab result is not treated as a standalone answer. A result below the local reference range needs confirmation with another fasting total testosterone draw between 6 and 10 in the morning on a separate occasion [1]. The final treatment decision sits with the VA care team under the current criteria for use. Your provider can explain how the criteria apply to your record, but this article cannot determine whether the VA will order testing or approve treatment.

If you want the full testing sequence in plain language, read the veteran low testosterone evaluation guide. The broader coverage hub covers other VA, TRICARE, and CHAMPVA gaps.

Why does the timing of the blood draw matter?

The VA workup specifies a fasting total testosterone draw between 6 and 10 in the morning [1]. The timing is part of the documented process, not a scheduling detail you can ignore. If your provider orders the evaluation, ask the lab and the care team how they want the fasting requirement and morning window handled.

If the first result is below the local reference range, the VA guidance calls for a second fasting draw between 6 and 10 in the morning on a separate occasion [1]. The second result confirms whether the low finding is repeated. A single abnormal result does not complete the biochemical assessment required by the criteria for use.

This is also why a same-day repeat is not the documented sequence. The guidance calls for confirmation on at least 2 separate occasions [1]. Put the lab instructions in your calendar, keep the first result, and ask what happens next if the second result is not below the local reference range.

The local reference range matters too. The VA guidance describes confirmation when a result is below the local reference range [1]. Do not compare a number from one lab with a range printed by another lab and assume the VA will read it the same way. Bring outside results to your provider, but let the VA care team decide how they fit the record.

You do not need to lead with a demand for a specific result. A useful request is more direct: ask whether your documented symptoms or findings support the VA low testosterone evaluation, and if they do, ask how to complete the required fasting morning draws.

Which symptoms or conditions make an evaluation appropriate?

The VA guidance does not say that every symptom associated with low testosterone should trigger testing. It says evaluation should happen in males with specific signs and symptoms, findings associated with hypogonadism, or a history of conditions that can cause it [1].

The guidance gives infertility and unexplained anemia as examples of findings associated with hypogonadism [1]. It also warns that undiagnosed chronic conditions can produce the same symptoms. Sleep apnea, obesity, and depression are named examples [1]. That makes the first appointment a clinical assessment, not merely a lab order.

This distinction matters when a veteran feels tired, notices a change in sexual function, or has another concern that can have several causes. The VA care team may ask about the full pattern, existing diagnoses, and other findings before deciding whether testosterone testing fits the criteria. A symptom can be real without proving that low testosterone is the cause.

The current rule therefore has 2 connected parts. You need a documented clinical reason to evaluate low testosterone, and you need the specified biochemical confirmation if testing is ordered [1]. Neither part replaces the other.

A practical conversation this week can stay focused. Tell the provider which symptoms or findings concern you, when they began, and whether you have known sleep apnea, obesity, depression, infertility, unexplained anemia, or another relevant condition. The provider reviews that information against the VA criteria for use. The official VA document and your care team have the final word.

The VA is good at care inside its documented process. If the concern is weight rather than testosterone, the VA weight loss program guide explains a different set of criteria. Do not treat the TRT rules and weight management rules as interchangeable.

Why did the VA create a tighter TRT process?

The backstory is documented. A 2018 VA Office of Inspector General healthcare inspection found that VA providers largely did not document clinically significant signs and symptoms consistent with androgen deficiency before starting testosterone. The inspection also found that providers often did not document risk and benefit discussions or conduct follow-up evaluation within 3 to 6 months [2].

The January 2026 VA guidance says the current criteria for use are based on that 2018 report, which found the diagnostic workup incomplete in the majority of veterans receiving testosterone prescriptions before the criteria took effect [1]. The March 2025 criteria are the VA's response to that recordkeeping and evaluation problem [1].

That history gives the current requirements a clear purpose. The VA wants the chart to show why evaluation is appropriate, then wants a repeated biochemical finding before treatment decisions. The process is meant to reduce decisions based on incomplete workups. It is not evidence that a veteran's symptoms are imaginary, and it is not a reason to dismiss a request without reviewing the person in front of the provider.

The inspection also matters because follow-up was part of the earlier gap. The OIG found that follow-up evaluation within 3 to 6 months was often not documented before the criteria existed [2]. The current guidance places the emphasis on a documented workup before treatment decisions. Your care team can explain the follow-up plan that applies if the evaluation proceeds.

If your provider says testing is not appropriate, ask which part of the VA guidance controls that decision. If testing is ordered, ask how the 6-10am fasting draws will be arranged. You are asking for the record to be clear, not asking the provider to skip the process.

What does the VA testosterone evaluation timeline look like?

The sequence is short enough to write down, but each step has a separate purpose. The first step is clinical documentation. The provider determines whether your symptoms, findings, or history support an evaluation under the criteria for use [1].

The next step is the first lab draw. It is a fasting total testosterone test between 6 and 10 in the morning [1]. If the result is below the local reference range, the next step is a confirmatory fasting draw between 6 and 10 in the morning on a separate occasion [1].

Only after the required clinical documentation and biochemical assessment are in the record does the criteria for use review address the treatment decision [1]. A veteran who arrives with one low result has useful information, but that result does not complete the documented VA sequence.

Here is the process you can screenshot before contacting your provider.

A table cannot decide whether your evaluation meets the criteria. It shows the order of the documented workup. The VA care team makes the clinical decision under the official criteria for use.

What to do next

Written for a veteran asking a VA provider about testosterone testing this week:

1. Write down the symptoms or findings you want to discuss, including when they began and how they affect you.
2. Ask your VA provider whether those symptoms, findings, or your medical history support a low testosterone evaluation under the March 2025 criteria for use [1].
3. Tell the provider whether sleep apnea, obesity, depression, infertility, unexplained anemia, or another relevant condition is already in your record [1].
4. If testing is appropriate, ask for a fasting total testosterone draw between 6 and 10 in the morning [1].
5. Save the first laboratory result and ask how the VA will arrange a second fasting draw between 6 and 10 in the morning on a separate occasion if the first result is below the local reference range [1].
6. Ask the care team which findings and laboratory results will go into the criteria for use review.
7. Keep the VA Formulary Advisor document and any written care team explanation with your laboratory results.
8. If the decision is unclear, ask the provider to identify whether the issue is the documented symptoms, the timing of the draw, the local reference range, or the need for confirmation.

Sources

1. VA Formulary Advisor, Evaluation for and Management of Males with Low Testosterone (January 2026), March 2025 criteria for use and VA evaluation sequence, accessed 2026-08-01, https://www.va.gov/formularyadvisor/DOC_PDF/CRE_Testosterone_Replacement_Therapy_Clinical_Recommendations_Jan_2026.pdf
2. VA Office of Inspector General, testosterone replacement therapy healthcare inspection (2018), prior VA documentation and follow-up findings, accessed 2026-08-01, https://www.vaoig.gov/reports/national-healthcare-review/healthcare-inspection-testosterone-replacement-therapy